Today: 7 February 2026
Subscribe
Browse Category

ASX:XRO.AX News 19 January 2026

Xero share price slides after Trump tariff threat hits tech — ASX:XRO sinks to 12‑month low

Xero share price slides after Trump tariff threat hits tech — ASX:XRO sinks to 12‑month low

Xero Ltd fell 2.6% to A$100.89 in Sydney, touching a 12-month low of A$98.23 during Monday’s session. The S&P/ASX 200 closed down 0.33%, pressured by losses in tech stocks after renewed U.S.-Europe tariff threats. Around 1.25 million Xero shares tied to its Melio acquisition became freely tradable last week. Traders are watching if Xero can hold above A$100 ahead of Tuesday’s open.
19 January 2026
···

Stock Market Today

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop